The purpose of this study was to investigate the differences and similarities of brain function in patients with four subtypes of obesity, and the relationship between brain function changes and complications after weight loss and metabolic improvement. 120 patients with obesity and 30 healthy individuals with normal BMI were enrolled.
Although the investigators have clinically observed significant differences in appetite and metabolic status in patients with the above four types of obesity, the brain functional characteristics of different obesity subtypes and their relationship with metabolic markers are still unclear. Based on this, in this project, the investigators plan to explore further the similarities and differences in brain function in patients with four subtypes of obesity and the relationship between brain function changes after weight loss and metabolic improvement and the occurrence of complications. 120 patients with obesity and 30 healthy individuals with normal BMI were enrolled. All patients with obesity underwent LSG. A multidisciplinary team evaluated participants with obesity at baseline, 1, 3, 6, and 12 months after laparoscopic sleeve gastrectomy (LSG). Anthropometrics, Metabolic indicators, sex hormones, menstruation,glucose-lipid metabolic markers, and hepatic steatosis assessed by FibroScan(CAP value and E value) were measured baseline and postoperative. Resting and task state functional magnetic resonance imaging (fMRI) measurements were performed at baseline for all participants at two-time points before and after meals. Measurements were repeated in obese patients 6 months after surgery.
Study Type
OBSERVATIONAL
Enrollment
150
Obese patients of different subtypes were all expected to undergo bariatric surgery
Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China
RECRUITINGFunctional magnetic resonance imaging of brain
The subjects underwent fMRI scans before and after eating. Blood oxygen levels depend on functional brain imaging (Blod-fMRI) to collect the brain's local BLOD response (hemodynamic response) caused by the electrical activity of neurons. The stronger the BLOD response, the more excitability of the local brain. A region-of-interest (ROI) approach was applied with the use of masks that were established in an independent study of normal-weight subjects to be markers of satiety or predictors of food choices. ROIs included the left and right ventral striatum (nucleus accumbens), the left and right amygdala, the left and right dorsal striatum (caudate and putamen), the left and right insula, and the medial orbital frontal cortex (mOFC). functional connectivity analysis analyzes the compatibity of temporal signals of two or more pairs of brain regions or the differences in the strength of functional connections under different experimental conditions
Time frame: 6 months
BMI
BMI=weight(kg)/height(m)\^2
Time frame: 12 months
Waist/hip Ratio
WHR(waist-hip ratio)=Waist Circumference in centimeter/Hip Circumference in centimeter
Time frame: 12 months
DXA(dual energy x-ray absorptiometry)
Dual X-ray Absorptiometry body composition analysis
Time frame: 12 months
Abdominal Fat Measurement
Abdominal Fat Measurement by B-mode Ultrasound
Time frame: 12 months
FBG
fasting blood-glucose in mmol/L
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
PBG
postprandial blood-glucose in mmol/L
Time frame: 12 months
FINS
fasting serum insulin in mU/L
Time frame: 12 months
PINS
postprandial insulin in mU/L
Time frame: 12 months
ALT
alanine aminotransferase in U/L
Time frame: 12 months
AST
aspartate aminotransferase in U/L
Time frame: 12 months
UA
Uric acid in umol/L
Time frame: 12 months
HOMA-IR
Homeostatic model assessment insulin resistance index=FBG\*FINS/22.5
Time frame: 12 months
HbA1c (%)
Glycated hemoglobin
Time frame: 12 months
LDL-C
low-density lipoprotein cholesterol in mmol/L
Time frame: 12 months
HDL-C
Hight-density lipoprotein cholesterol in mmol/L
Time frame: 12 months
TT
total testosterone in nmol/L
Time frame: 12 months
SHBG
sex hormone-binding globulin in nmol/L
Time frame: 12 months
TSH
thyroid stimulating hormone in μIU/ml
Time frame: 12 months
FT3
free triiodothyronine in pmol/L
Time frame: 12 months
FT4
free thyroxine in pmol/L
Time frame: 12 months
FT
free testosterone (nmol/L)
Time frame: 12 months
DHEAS
Dehydroepiandrosterone Sulfate (ug/dl)
Time frame: 12 months
PTH
parathyroid hormone in (ng / L)
Time frame: 12 months
25OHD
25 hydroxyvitamin D in (nmol / L)
Time frame: 12 months
Ca
serum calcium in (mmol/L)
Time frame: 12 months
GLP-1
Glucagon-like peptide-1(pmol/L)
Time frame: 12 months
LCN2
Lipocalin 2 level
Time frame: 12 months
Ghrelin
Ghrelin level
Time frame: 12 months
Leptin
Leptin level
Time frame: 12 months
S100
S100 protein level
Time frame: 12 months
GFAP
Glial fibrillary acidic protein level
Time frame: 12 months
TEFQ-R21
The TFEQ-R21 consisted of 21 items rated on a four-point Likert scale. We averaged the scores (ranging from 1 to 4) for the overall items as well as the items within the subdomain of each item, i.e., EE, UE, and CR, where a higher score indicated a more dysfunctional eating behavior.
Time frame: 12 months
HADS
HADS consists of two subscales: HADS-A, designed to detect anxious states, and HADS-D, designed to detect depressive states. Each subscale consists of seven items with a 4-point ordinal response format. Scores ranges from 0 to 21 in each subscale, with higher scores indicating higher levels of anxious or depressive state. Participants answer each item thinking of how they felt and/or behaved during the past week.
Time frame: 12 months